MXPA05006326A - Derivados diversamente sustituidos de guanidina, y su uso como medicamentos con actividad anti-diabetes y/o anti-obesidad. - Google Patents

Derivados diversamente sustituidos de guanidina, y su uso como medicamentos con actividad anti-diabetes y/o anti-obesidad.

Info

Publication number
MXPA05006326A
MXPA05006326A MXPA05006326A MXPA05006326A MXPA05006326A MX PA05006326 A MXPA05006326 A MX PA05006326A MX PA05006326 A MXPA05006326 A MX PA05006326A MX PA05006326 A MXPA05006326 A MX PA05006326A MX PA05006326 A MXPA05006326 A MX PA05006326A
Authority
MX
Mexico
Prior art keywords
diabetes
medicines
guanidine
substituted derivatives
variously substituted
Prior art date
Application number
MXPA05006326A
Other languages
English (en)
Spanish (es)
Inventor
Corelli Federico
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of MXPA05006326A publication Critical patent/MXPA05006326A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215Radicals derived from nitrogen analogues of carbonic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/12Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/18Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
MXPA05006326A 2002-12-17 2003-12-01 Derivados diversamente sustituidos de guanidina, y su uso como medicamentos con actividad anti-diabetes y/o anti-obesidad. MXPA05006326A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000625A ITRM20020625A1 (it) 2002-12-17 2002-12-17 Derivati di guanidine variamente sostituite, loro uso come medicamenti ad attivita' antidiabetica e/o antiobesita'.
PCT/IT2003/000792 WO2004054967A1 (en) 2002-12-17 2003-12-01 Variously substituted derivatives of guanidine, and their use as medicines with anti-diabetes and/or anti-obesity activity

Publications (1)

Publication Number Publication Date
MXPA05006326A true MXPA05006326A (es) 2005-08-26

Family

ID=32587901

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05006326A MXPA05006326A (es) 2002-12-17 2003-12-01 Derivados diversamente sustituidos de guanidina, y su uso como medicamentos con actividad anti-diabetes y/o anti-obesidad.

Country Status (12)

Country Link
US (1) US7368605B2 (https=)
EP (1) EP1575912A1 (https=)
JP (1) JP2006509816A (https=)
KR (1) KR20050089058A (https=)
CN (1) CN1729172A (https=)
AU (1) AU2003288534B2 (https=)
BR (1) BR0317397A (https=)
CA (1) CA2506685A1 (https=)
IT (1) ITRM20020625A1 (https=)
MX (1) MXPA05006326A (https=)
PL (1) PL378416A1 (https=)
WO (1) WO2004054967A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2873368B1 (fr) * 2004-07-26 2008-01-04 Merck Sante Soc Par Actions Si Derives de guanidine et leurs utilisations en therapeutique
CN101062906B (zh) * 2006-04-26 2012-02-08 中国人民解放军军事医学科学院毒物药物研究所 胍丁胺硫酸盐水合物及其用于戒毒,抗炎,降血糖以及胍丁胺代谢异常所致疾病的用途
CN101121677B (zh) * 2006-08-09 2011-05-11 中国人民解放军军事医学科学院毒物药物研究所 胍丁胺硫酸盐二水合物及其医药用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU190639B (en) * 1983-12-12 1986-09-29 Gyogyszerkutato Intezet Kv,Hu Process for production of new aminoguanidin derivatives
IT1219846B (it) * 1988-02-24 1990-05-24 Consiglio Nazionale Ricerche Nuovi derivati guandinici ad attivita' ipotensia,composizione che li contengono e relativo procedimento di estrazione e purificazione da materiale botanico
JPH06510760A (ja) * 1991-08-27 1994-12-01 ジ・アップジョン・カンパニー 代謝障害および代謝の治療法
GB9511757D0 (en) * 1995-05-19 1995-08-02 Univ Strathclyde Agents for reducing weight
KR19990076594A (ko) * 1995-12-22 1999-10-15 피터 존 기딩스 Niddm 치료용 아미노구아니딘

Also Published As

Publication number Publication date
CN1729172A (zh) 2006-02-01
WO2004054967A1 (en) 2004-07-01
AU2003288534B2 (en) 2009-07-02
PL378416A1 (pl) 2006-04-03
US7368605B2 (en) 2008-05-06
JP2006509816A (ja) 2006-03-23
KR20050089058A (ko) 2005-09-07
ITRM20020625A1 (it) 2004-06-18
EP1575912A1 (en) 2005-09-21
US20060069100A1 (en) 2006-03-30
BR0317397A (pt) 2005-11-16
AU2003288534A1 (en) 2004-07-09
CA2506685A1 (en) 2004-07-01

Similar Documents

Publication Publication Date Title
GT200100183A (es) Derivados de quinolina y quinazolina.
BR0107815A (pt) Derivados aminados de di-hidro-1,3,5-triazina e suas aplicações em terapêutica
MY135222A (en) Substituted phenylacetamides and their use as glucokinase activators
ES2171077T3 (es) Composicion para mejorar el metabolismo de la glucosa y de la insulina en animales de compañia.
CY1110753T1 (el) Αναστολεις της 11-βητα-υδροξυστεροειδους αφυδρογονασης i
WO2005113606A3 (en) Fgf-21 fusion proteins
SE9801992D0 (sv) New 3-aryl-2-hydroxypropionic acid derivative I
HUP0300725A2 (hu) Az inzulinrezisztencia-szindróma kezelése CGMP PDE5 inhibitorokkal
MXPA04006802A (es) Derivados de acido fenil(alquil)carboxilico y derivados fenilalquilheterociclicos dionicos y su uso como medicinas con actividad reductora de glucosa en suero y/o de lipidos en suero..
MX2008004734A (es) Composicion rica en leucina.
KR970704440A (ko) 당뇨병 타입 ⅱ의 치료용 약물에의 케토코나졸 및 관련 물질의 용도(use of ketoconazole and related substances in medicaments for treatment of type ⅱ diabetes)
EP1561472A4 (en) SOLID PREPARATION
WO2006114805A3 (en) Use of hmgb2 and hmgb3 proteins for medical applications
TW200420531A (en) Use of α-phenylthiocarboxylic and α-phenyloxycarboxylic acids with serum-glucose-lowering and serum-lipid-lowering activity
TNSN05065A1 (en) Use of prebiotics for the treatment and prevention of hyperglycaemic syndromes
SE0302129D0 (sv) Farmaceutiska kompositioner med antibiotisk aktivitet
MXPA03002160A (es) Metodo para el tratamiento de resistencia a insulina en obesidad y diabetes.
ATE266632T1 (de) Kreatin-salz mit nahrungs- und therapeutischer verwendung und dieses enthaltende zusammensetzungen
MXPA05006326A (es) Derivados diversamente sustituidos de guanidina, y su uso como medicamentos con actividad anti-diabetes y/o anti-obesidad.
IL172898A0 (en) Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus
CY1107312T1 (el) Θειικη 3,5,3’-τριιωδοθυρονινη σαν θυρεοειδο-μιμητικος παραγοντας και φαρμακευτικα σκευασματα της
DE60323138D1 (de) Kombinationsarzneimittel aus r,r-formoterol und ciclesonide
ATE461968T1 (de) Antimikrobielle kunststoffzusammensetzung mit niedriger elutionsrate und langer wirksamkeit
BR0208109A (pt) Derivados de guanidina bicìclicos e usos terapêuticos destes
BR9913149A (pt) Derivados de piperazina antidiabéticos, processos para sua preparação e composições contendo os mesmos

Legal Events

Date Code Title Description
FA Abandonment or withdrawal